#metabolic-disease
#metabolic-disease

[ follow ]

Snapshots of acyl carrier protein shuttling in human fatty acid synthase - Nature

De novo lipogenesis is crucial for mammalian development and metabolic health, particularly during disease states.

Targeting the FASN enzyme shows therapeutic potential but requires careful consideration of its broader physiological effects.

Trust in public health has diminished, leading some to reject vaccines and align with alternative health narratives.

High-fat diets lead to neurotransmitter surges that drive fatty acid release in the liver, contributing to metabolic diseases.

Startup companies

BioAge Labs Inc. is raising up to $157.5 million in its IPO targeting therapies for obesity and metabolic diseases.

The initial price range suggests a company market value of about $587 million.

Key investors include CEO Kristen Fortney and prominent venture capital firms.

High-fat diets lead to neurotransmitter surges that drive fatty acid release in the liver, contributing to metabolic diseases.

Startup companies

BioAge Labs Inc. is raising up to $157.5 million in its IPO targeting therapies for obesity and metabolic diseases.

The initial price range suggests a company market value of about $587 million.

Key investors include CEO Kristen Fortney and prominent venture capital firms.

[ Load more ]